January 3, 2023
The University of Cincinnati's Eva Mistry is leading a new study with funding support from the Patient-Centered Outcomes Research Institute that will examine the effectiveness of a stroke treatment for patients with a pre-stroke disability, one of the first studies to focus on this population.
June 3, 2022
The University of Cincinnati's Jensine' Clark and Emily Nurre lead transition clinics that help guide patients with childhood-onset disabilities and epilepsy from pediatric to adult care.
September 15, 2022
The University of Cincinnati Gardner Neuroscience Institute is transforming into a Learning Health System, a data-driven, patient-centered approach with the goal of measurably improving outcomes for patients with neurological disorders.
July 13, 2022
The University of Cincinnati's Dr. Hyacinth I. Hyacinth is leading two research projects to learn more about the relationship between sickle cell disease, stroke and cognitive impairment.
April 5, 2022
The University of Cincinnati's Dr. Hyacinth I. Hyacinth is researching how different rates of cerebral small vessel disease and genetic differences contribute to higher rates of Alzheimer's disease and related dementias in non-Hispanic Black populations compared to non-Hispanic white patients.
April 21, 2023
The University of Cincinnati's Alberto Espay will present Parkinson's disease research at the American Academy of Neurology's annual meeting April 22-27 in Boston.
May 15, 2023
University of Cincinnati’s Melanie Thomas-Castillo, PsyD, and Stephen Rush, MD, recently published commentary on how psychiatrists can work to create a supportive environment for transgender and gender diverse patients in the journal Current Psychiatry.
October 4, 2022
University of Cincinnati researchers led by Alberto Espay and Andrea Sturchio published new research that supports the hypothesis that Alzheimer’s disease is caused by a decline in levels of a protein called amyloid-beta.
December 7, 2023
The UC Gardner Neuroscience Institute has received $19 million in federal funding from the National Institutes of Health to serve as the lead center for a Phase 2 clinical trial that will study the efficacy of a new monoclonal antibody treatment for patients ineligible for currently available treatments.
October 27, 2023
A new large-scale study led by researchers at the University of Cincinnati and Northwell Health found the drug metformin can help prevent or reduce weight gain in youth taking medication to treat bipolar disorder.